US to continue supporting Georgia in achieving elimination of Hepatitis C, B
Georgia launched its large-scale Hepatitis C Elimination Programme in partnership with the American company Gilead in 2015, aiming to eliminate the virus by 2020. Photo: www.prevention.gov.ge.
Tweet 
Share
The United States will continue to support Georgian health authorities in their goal of achieving elimination of Hepatitis C and B in the country, the US Embassy to Georgia said on Monday.
The Embassy released figures showing results of the latest Georgia Hepatitis Elimination Programme, with the progress report showing 2.3 million adults in Georgia having been screened for hepatitis C.
The number includes 96,000 patients identified with chronic HCV, with over 78,000 of them treated for the condition.
The nationwide serosurvey conducted in 2021 shows that the proportion of the population with chronic HCV infection decreased from 5.4% to 1.8%. For Hepatitis B, national coverage for childhood vaccination remains high confirming achievement for regional control targets,” the US diplomatic office said.
Georgia launched its large-scale Hepatitis C Elimination Programme in partnership with the American company Gilead in 2015, aiming to eliminate the virus by 2020.
With the help of the United States, Georgia will bring in new medicine which is likely to completely defeat Hepatitis C in Georgia by 2020.
According to three years results of the Hepatitis C elimination programme, 50,000 people are involved in the process currently and treatment rate is 98,2 percent.
A new modern centre for Hepatitis C management has opened in the town of Zugdidi in Georgia’s western Samegrelo region today.
PM stresses Georgia’s “stunning achievements”
Today the world marks Hepatics Day in order to bring different people together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change.
The Georgian Government will launch a new programme for the elimination of Hepatitis B this year, Tengiz Tsertsvadze, the head of the Infectious Diseases and AIDS Centre, revealed in an interview with the news agency InterPressNews on Tuesday.